High density lipoprotein cholesterol and the risk of stroke in elderly men: the Honolulu heart program.
暂无分享,去创建一个
K. Yano | R. Abbott | G. Ross | K. Masaki | H. Petrovitch | J. Curb | Randi Chen | B. Rodríguez | J. Popper | I. Schatz | Gina C. Belleau
[1] A. Hardy,et al. Mortality , 1953, The Panama Railroad.
[2] J. Michael Gaziano,et al. Cholesterol and the Risk of Ischemic Stroke , 2003, Stroke.
[3] R. Abbott,et al. Age-related changes in risk factor effects on the incidence of thromboembolic and hemorrhagic stroke. , 2003, Journal of clinical epidemiology.
[4] D. Tanné,et al. Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry. , 2002, Archives of internal medicine.
[5] P. Elwood,et al. Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe , 2002, Journal of epidemiology and community health.
[6] R. D'Agostino,et al. Risk of Hospitalized Stroke in Men Enrolled in the Honolulu Heart Program and the Framingham Study: A Comparison of Incidence and Risk Factor Effects , 2002, Stroke.
[7] K. Yano,et al. Ankle-brachial blood pressure in elderly men and the risk of stroke: the Honolulu Heart Program. , 2001, Journal of clinical epidemiology.
[8] L. Brass,et al. Reduction in Stroke With Gemfibrozil in Men With Coronary Heart Disease and Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) , 2001, Circulation.
[9] R. Sacco,et al. High‐density lipoprotein cholesterol and ischemic stroke in the elderly: The Northern Manhattan Stroke Study , 2001, JAMA.
[10] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[11] D. Sprecher. Raising high-density lipoprotein cholesterol with niacin and fibrates: a comparative review. , 2000, The American journal of cardiology.
[12] S. Ebrahim,et al. HDL-Cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. , 2000, Stroke.
[13] D. Rader,et al. Overexpression of Secretory Phospholipase A2 Causes Rapid Catabolism and Altered Tissue Uptake of High Density Lipoprotein Cholesteryl Ester and Apolipoprotein A-I* , 2000, The Journal of Biological Chemistry.
[14] Aldons J. Lusis,et al. Atherosclerosis : Vascular biology , 2000 .
[15] K. Yano,et al. Screening for coronary heart disease in elderly men based on current and past cholesterol levels. , 1999, Journal of clinical epidemiology.
[16] J. Qiao,et al. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[17] K. Yano,et al. Changes in total and high-density lipoprotein cholesterol over 10- and 20-year periods (the Honolulu Heart Program). , 1998, The American journal of cardiology.
[18] Alan C. Wilson,et al. Risk factors for stroke and type of stroke in persons with isolated systolic hypertension , 1998 .
[19] Y. Friedlander,et al. Risk factors for ischemic stroke: Dubbo Study of the elderly. , 1998, Stroke.
[20] R. D'Agostino,et al. Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. , 1997, The New England journal of medicine.
[21] D. Tanné,et al. High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. , 1997, Stroke.
[22] L. Chambless,et al. Association of transient ischemic attack/stroke symptoms assessed by standardized questionnaire and algorithm with cerebrovascular risk factors and carotid artery wall thickness. The ARIC Study, 1987-1989. , 1996, American journal of epidemiology.
[23] A. von Eckardstein,et al. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. , 1996, Atherosclerosis.
[24] J. Gamble,et al. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[25] R. Glynn,et al. HDL cholesterol predicts coronary heart disease mortality in older persons. , 1995, JAMA.
[26] K. Anderson,et al. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. , 1994, Journal of gerontology.
[27] A. Folsom,et al. High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. , 1994, Circulation.
[28] D. Reed,et al. Trends in Stroke Incidence and Mortality in Hawaiian Japanese Men , 1994, Stroke.
[29] C. Burchfiel,et al. Physical activity in older middle-aged men and reduced risk of stroke: the Honolulu Heart Program. , 1994, American journal of epidemiology.
[30] C. Abbott,et al. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. , 1993, Atherosclerosis.
[31] W. L. Ooi,et al. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[32] Y. Friedlander,et al. Dubbo Study of the elderly: hypertension and lipid levels. , 1992, Atherosclerosis.
[33] W. Willett,et al. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.
[34] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[35] A. Tall. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. , 1990, The Journal of clinical investigation.
[36] J Pekkanen,et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. , 1990, The New England journal of medicine.
[37] D. Gordon,et al. High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.
[38] P. Wilson,et al. High Density Lipoprotein Cholesterol, Total Cholesterol Screening, and Myocardial Infarction: The Framingham Study , 1988, Arteriosclerosis.
[39] D. Reed,et al. Coronary heart disease, hypertension and stroke among Japanese-American men in Hawaii: the Honolulu Heart Program. , 1985, Hawaii medical journal.
[40] P. W. Lane,et al. Analysis of covariance and standardization as instances of prediction. , 1982, Biometrics.
[41] W. Kannel,et al. Lipoproteins, cardiovascular disease, and death. The Framingham study. , 1981, Archives of internal medicine.
[42] S B Hulley,et al. HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.
[43] S. Syme,et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. , 1974, Journal of chronic diseases.
[44] D. Cox. Regression Models and Life-Tables , 1972 .